GSTM1 and colorectal carcinoma: Our study shows that compared to the current CRC screening strategy in Ontario (biennial gFOBT between age 50–74 years), replacing gFOBT by FIT with a cut-off level of 200 ng Hb/ml provides more QALYs at lower costs, without increasing the number of colonoscopies required.